NVS • NYSE
Novartis AG
$89.54
After Hours:
$89.54
(0.00%)0.00
Closed: Jan 18, 4:07:26 PM GMT-5 · USD · NYSE · Disclaimer
StockUS listed securityCH headquartered
Previous close
$90.55
Day range
$89.01 - $89.84
Year range
$79.34 - $98.52
Market cap
219.63B USD
Volume
2.66M
P/E ratio
20.63
Dividend yield
3.57%
CDP Climate Change Score
B
In the news
Financial performance
(USD)Sep 2021Year/year change
Revenue
13.37B6.61%
Net income
2.76B42.53%
Diluted EPS1.2245.24%
Net profit margin20.63%33.70%
Operating income3.58B35.98%
Net change in cash2.09B-31.95%
Cash on hand--
Cost of revenue3.85B2.53%
About
Novartis International AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. It is one of the largest pharmaceutical companies in the world. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. In March 1996, the companies Ciba-Geigy and Sandoz merged to form Novartis; the pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. Other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Novartis divested its agrochemical and genetically modified crops business in 2000 with the spinout of Syngenta in partnership with AstraZeneca, which also divested its agrochemical business. Wikipedia
Founded
Feb 29, 1996
Employees
108,000
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more